Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.8.2025Dr. Falk Pharma GmbH (FAK)11806Budenofalk rektálna pena (spm rec 1x14 dávok/28 mg (nád.Al.tlak.))4.6.2025O
 1.8.2025Desitin Arzneimitttel GmbH (DET)2401BOspolot (tbl flm 50x200 mg (obal PE))1.8.2025O
 1.8.2025Aspen Pharma Trading Limited (ASE-1)97170Ovestin (crm vag 1x15 g (tuba Al+aplikátor))23.7.2025O
 31.7.2025Teva B.V. (TEV-NL-4)34950MEGESIN 160 mg (tbl 100x160 mg)17.7.2025O
 31.7.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)51855Montelukast Teva 10 mg (tbl flm 98x10 mg (blis.Al/Al))25.8.2025R
 31.7.2025Zentiva, k.s. (ZNT-1)00858Hydrocortison Léčiva (ung 1x10 g (tuba Al))1.8.2025O
 31.7.2025Zentiva, k.s. (ZNT-1)3049BTorvacard Novum 20 mg (tbl flm 30x20 mg (blis.OPA/Al/PVC/Al))1.8.2025O
 31.7.2025Egis Pharmaceuticals PLC (EGI)33239Erolin (tbl 30x10 mg (blis.PVC/PVDC/Al))10.8.2025Z
 31.7.2025Egis Pharmaceuticals PLC (EGI)31200Sindranol 2 mg (tbl plg 84x2 mg (blis.PVC/PCTFE/Al))10.8.2025Z
 31.7.2025Swyssi AG (SWY)5162BCandesartan HCT Swyssi 16 mg/12,5 mg (tbl 30x16 mg/12,5 mg (blis.OPA/Al/PVC/Al))31.7.2025Z
 31.7.2025Swyssi AG (SWY)5161BCandesartan HCT Swyssi 8 mg/12,5 mg (tbl 30x8 mg/12,5 mg (blis.OPA/Al/PVC/Al))31.7.2025Z
 31.7.2025Grifols Deutschland GmbH (GIO)4987CGamunex (sol inf 1x50 ml (liek.inj.skl.))31.7.2025O
 31.7.2025Grifols Deutschland GmbH (GIO)4990CGamunex (sol inf 1x400 ml (liek.inj.skl.))31.7.2025O
 31.7.2025TS Pharma s.r.o. (TPH-1)37388Tarka 240 mg/4 mg tablety (tbl flm 56x240 mg/4 mg (blis.PVC/PVDC/Al))1.8.2025O
 31.7.2025Mylan Pharmaceuticals Limited (MLB-IE-1)2714CEmtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg filmom obalené tablety (tbl flm 30x200 mg/245 mg (fľ.HDPE))4.8.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To